Phospholipid binding lowers immunogenicity of human recombinant factor VIII in von Willebrand factor knockout mice
- PMID: 21475771
- PMCID: PMC3970404
- DOI: 10.1160/TH10-09-0628
Phospholipid binding lowers immunogenicity of human recombinant factor VIII in von Willebrand factor knockout mice
Figures



Similar articles
-
To serve and protect: The modulatory role of von Willebrand factor on factor VIII immunogenicity.Blood Rev. 2017 Sep;31(5):339-347. doi: 10.1016/j.blre.2017.07.001. Epub 2017 Jul 4. Blood Rev. 2017. PMID: 28716211 Review.
-
[Importance of the study of the binding of factor VIII to von Willebrand factor in hemophilia A].Sangre (Barc). 1992 Jun;37(3):211-24. Sangre (Barc). 1992. PMID: 1359656 Spanish. No abstract available.
-
Epitope specificity of anti-FVIII antibodies during immune tolerance therapy with factor VIII preparation containing von Willebrand factor.Thromb Res. 2002 Sep 15;107(6):291-302. doi: 10.1016/s0049-3848(02)00352-3. Thromb Res. 2002. PMID: 12565716
-
New characteristics of anti-factor VIII inhibitor antibody epitopes and unusual immune responses to Factor VIII.Semin Thromb Hemost. 2002 Jun;28(3):291-6. doi: 10.1055/s-2002-32665. Semin Thromb Hemost. 2002. PMID: 12098091
-
Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions.Acta Haematol. 2009;121(2-3):102-5. doi: 10.1159/000214849. Epub 2009 Jun 8. Acta Haematol. 2009. PMID: 19506355 Review.
Cited by
-
Native-like aggregates of factor VIII are immunogenic in von Willebrand factor deficient and hemophilia a mice.J Pharm Sci. 2012 Jun;101(6):2055-65. doi: 10.1002/jps.23091. Epub 2012 Mar 2. J Pharm Sci. 2012. PMID: 22388918 Free PMC article.
References
-
- Klinge J, Ananyeva NM, Hauser CA, et al. Hemophilia A--from basic science to clinical practice. Semin Thromb Hemost. 2002 Jun;28(3):309–322. - PubMed
-
- Pratt KP, Thompson AR. B-cell and T-cell epitopes in anti-factor VIII immune responses. Clin Rev Allergy Immunol. 2009 Oct;37(2):80–95. - PubMed
-
- Ananyeva NM, Lacroix-Desmazes S, Hauser CA, et al. Inhibitors in hemophilia A: mechanisms of inhibition, management and perspectives. Blood Coagul Fibrinolysis. 2004 Mar;15(2):109–124. - PubMed
-
- Jacquemin MG, Saint-Remy JM. Factor VIII immunogenicity. Haemophilia. 1998 Jul;4(4):552–557. - PubMed